These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7512902)

  • 1. Genital herpes. A guide to pharmacological therapy.
    de Ruiter A; Thin RN
    Drugs; 1994 Feb; 47(2):297-304. PubMed ID: 7512902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
    Wagstaff AJ; Faulds D; Goa KL
    Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current recommendations for the treatment of genital herpes.
    Leung DT; Sacks SL
    Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Faulds D
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
    Bodsworth NJ; Crooks RJ; Borelli S; Vejlsgaard G; Paavonen J; Worm AM; Uexkull N; Esmann J; Strand A; Ingamells AJ; Gibb A
    Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
    Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
    Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.
    Scoular A; Barton S
    Genitourin Med; 1997 Oct; 73(5):391-3. PubMed ID: 9534751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic and therapeutic recommendations for sexually transmitted diseases: Genital herpes].
    Milpied B; Janier M; Timsit J; Spenatto N; Caumes E; Chosidow O; Sentilhes L; Senat MV;
    Ann Dermatol Venereol; 2019 Jan; 146(1):31-36. PubMed ID: 30366717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.
    Conant MA; Schacker TW; Murphy RL; Gold J; Crutchfield LT; Crooks RJ;
    Int J STD AIDS; 2002 Jan; 13(1):12-21. PubMed ID: 11802924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Sénat MV; Anselem O; Picone O; Renesme L; Sananès N; Vauloup-Fellous C; Sellier Y; Laplace JP; Sentilhes L
    Gynecol Obstet Fertil Senol; 2017 Dec; 45(12):705-714. PubMed ID: 29132768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.
    Scott LL; Sanchez PJ; Jackson GL; Zeray F; Wendel GD
    Obstet Gynecol; 1996 Jan; 87(1):69-73. PubMed ID: 8532270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
    Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
    Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
    Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.
    Keller MJ; Malone AM; Carpenter CA; Lo Y; Huang M; Corey L; Willis R; Nguyen C; Kennedy S; Gunawardana M; Guerrero D; Moss JA; Baum MM; Smith TJ; Herold BC
    J Antimicrob Chemother; 2012 Aug; 67(8):2005-12. PubMed ID: 22556381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of neonatal herpes simplex virus infection.
    Kesson AM
    Paediatr Drugs; 2001; 3(2):81-90. PubMed ID: 11269641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus.
    Bryson YJ
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF).
    Sénat MV; Anselem O; Picone O; Renesme L; Sananès N; Vauloup-Fellous C; Sellier Y; Laplace JP; Sentilhes L
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():93-101. PubMed ID: 29571124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genital herpes].
    Boralevi F; Geniaux M
    Rev Prat; 1996 Oct; 46(16):1952-60. PubMed ID: 9005519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.